Trademark: 79331034
Word
DIGICELL
Status
Registered
Status Code
700
Status Date
Tuesday, February 21, 2023
Serial Number
79331034
Registration Number
6982561
Registration Date
Tuesday, February 21, 2023
Mark Type
4
Filing Date
Wednesday, September 8, 2021
Published for Opposition
Tuesday, December 6, 2022

Trademark Owner History
Bit Bio Limited - Original Registrant

Classifications
40 Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live
9 Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and to control laboratory manufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; laboratory apparatus for magnetic cell separation
29 Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live
5 Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical, therapeutic or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use for drug screening; cell preparations for genetic testing, screening for medical purposes or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical, diagnostic or clinical use; tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical use; cell separation reagents for medical, therapeutic or clinical use; dietary supplements; protein supplements; nutrition supplements
1 Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use, not for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical research use
42 Biotechnology research; biotechnology testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely, biological research; stem cell biology services, namely, biological research; scientific research, laboratory, development and consulting services for scientific, research, clinical, medical, and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing and screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation for scientific, research, clinical, medical, and manufacturing purposes; cell separation research services; consultancy relating to biotechnology; consultancy relating to drug screening; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Trademark Events
Jun 23, 2022
Non-Final Action Written
Jan 13, 2022
Sn Assigned For Sect 66a Appl From Ib
Jan 14, 2022
New Application Office Supplied Data Entered
Jan 18, 2022
Application Filing Receipt Mailed
Jun 13, 2022
Assigned To Examiner
Jun 24, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 29, 2022
Refusal Processed By Mpu
Jun 29, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 23, 2022
Correction Transaction Received From Ib
Jul 26, 2022
Refusal Processed By Ib
Aug 11, 2022
Teas Response To Office Action Received
Aug 11, 2022
Correspondence Received In Law Office
Aug 11, 2022
Teas/Email Correspondence Entered
Sep 23, 2022
Examiners Amendment -Written
Sep 23, 2022
Examiners Amendment E-Mailed
Sep 23, 2022
Notification Of Examiners Amendment E-Mailed
Sep 23, 2022
Examiner's Amendment Entered
Sep 23, 2022
Approved For Pub - Principal Register
Oct 11, 2022
Withdrawn From Pub - Og Review Query
Oct 28, 2022
Correction From The Ib Examined, No Action Is Needed
Nov 2, 2022
Previous Allowance Count Withdrawn
Nov 3, 2022
Examiners Amendment -Written
Nov 3, 2022
Examiners Amendment E-Mailed
Nov 3, 2022
Notification Of Examiners Amendment E-Mailed
Nov 3, 2022
Examiner's Amendment Entered
Nov 3, 2022
Approved For Pub - Principal Register
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 23, 2022
Notification Of Possible Opposition Sent To Ib
Dec 6, 2022
Published For Opposition
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Notification Processed By Ib
Dec 21, 2022
Teas Post Publication Amendment Received
Jan 17, 2023
Assigned To Petition Staff
Jan 20, 2023
Changes/Corrections After Pub Approval Entered
Feb 21, 2023
Registered-Principal Register
Feb 21, 2023
Notice Of Registration Confirmation Emailed
May 4, 2024
New Representative At Ib Received
Jun 13, 2023
Final Decision Transaction Processed By Ib
May 21, 2023
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2023
Final Disposition Processed
May 24, 2023
Final Disposition Notice Sent To Ib

Trademark Alertz updated from USPTO on 2030-01-24